FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia
Science Advances · 2025
DOI: 10.1126/sciadv.adv7648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Wenlong Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL 60…. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Leukemia, Myeloid, Acute, Protein Biosynthesis, Ribosomes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Targeting ribosome biogenesis and protein translation has emerged as a promising avenue for cancer therapy. The fat mass and obesity-associated protein (FTO), an RNA N 6 -methyladenosine (m 6 A) eraser, has been identified as an oncogenic factor in acute myeloid leukemia (AML). Here, we present the development of an FTO degrader that selectively degrades FTO in AML cells, demonstrating superior efficacy both in vitro and in vivo. We confirmed that FTO degradation increases m 6 A modifications on mRNAs associated with ribosome biogenesis, promoting their YTHDF2-mediated decay. This disruption of ribosome biogenesis and protein translation contributes to the inhibition of AML progression. Our findings highlight this FTO degrader as a valuable tool compound for elucidating the functional roles of FTO in cancer and as a potential foundation for the development of selective anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL 60637, USA.
- Howard Hughes Medical Institute, University of Chicago, Chicago, IL 60637, USA.
- Department of Systems Biology, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
- Center for RNA Biology and Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
- Department of Hematology, The First Affiliated Hospital, Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
- Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
ORCID-Profile: Wenlong Li, Yutao Zhao, Zhenhua Chen, Ying Qing, Jianjun Chen, Chuan He
Förderung
- NHLBI NIH HHS
- NHGRI NIH HHS
- NCI NIH HHS
Zitieren
APA
Li, W., Zhao, Y., Wu, D., Chen, Z., Qing, Y., Yang, F., Ji, F., Zhang, L., Sau, L., Chen, J., & He, C. (2025). FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia. Science Advances. https://doi.org/10.1126/sciadv.adv7648
Vancouver
Li W, Zhao Y, Wu D, Chen Z, Qing Y, Yang F, et al. FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia. Science Advances. 2025. doi:10.1126/sciadv.adv7648
BibTeX
@article{Li2025,
author = {Li, Wenlong and Zhao, Yutao and Wu, Dong and Chen, Zhenhua and Qing, Ying and Yang, Fan and Ji, Fei and Zhang, Linda and Sau, Lillian and Chen, Jianjun and He, Chuan},
title = {FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adv7648}
}
EUVIMED